Inter-relationship between chemokines and mast cells

European Journal of Inflammation

Volumn 8, Issue 1, 2010, Pages 7-14

  Castellani, Maria Luisa ^a   Anogeianaki, A ^b   Toniato, E ^a   De Lutiis, M A ^a   Felaco, P ^a   Fulcheri, M ^a   Vecchiet, J ^a   Tete S ^a   Salini, V ^a   Caraffa, A ^c   Antinolfi, P ^c   Theoharides, T C ^d   Conti, F ^a   Cuccurullo, C ^a   Ciampoli, C ^a   Felaco, M ^a   Orso, C ^a   Cerulli, G ^c   Frydas, I ^b   Shaik, B ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF PERUGIA   (Italy)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Cytokines; Inflammation; Mast cells

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CHEMOKINE; CHEMOKINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLERGIC DISEASE; CELL DIFFERENTIATION; CELL STIMULATION; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; REVIEW; SECRETORY GRANULE;

EID: 77952682043     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1000800102     Document Type: Review

References (66)

1. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "Intercrine" cytokine family. Annu Rev Immunol 1991; 9:617-623
2. Felaco P, Toniato E, Castellani ML, et al. Infections and mast cells. J Biol Regul Homeost Agents 2009; 23:231-238
3. Castellani ML, Felaco M, Pandolfi F, et al. IL-32: a newly-discovered proinflammatory cytokine. J Biol Regul Homeost Agents 2009; 23:141-147
4. Di Bonito P, Grasso F, Mangino G, et al. Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells. Int J Immunopathol Pharmacol 2009; 22:967-968
5. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews: Immunology 2005; 5:953-962
6. Karapanou V, Kempuraj D, Theoharides TC. Oral neuroimmune network and mast cells. Eur J Inflamm 2009; 7:1-8.
7. Di Paola R, Crisafulli C, Mazzon E, Genovese T, Paterniti I, Bramanti P, Cuzzocrea S. Effect of PD98059, a selective MAPK3/MAPK1 inhibitor, on acute lung injury in mice. Int J Immunopathol Pharmacol 2009; 22:937-950
8. Di Lorenzo G, Mansueto P, Pacor ML, et al. Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1077-1087
9. Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol 2009; 182:3945-3946
10. Gibbs BF. Differential modulation of IgE-dependent activation of human basophils by ambroxol and related secretolytic analogues. Int J Immunopathol Pharmacol 2009; 22:919-927
11. Castellani ML, Kempuraj DJ, Salini V, et al. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents 2009; 23:11-14.
12. Lew W, Oppenheim JJ, Matsushima K. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol 1988; 140:1895-1902
13. Zuccotti GV, Trabattoni D, Morelli M, Borgonovo S, Schneider L, Clerici M. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J Biol Regul Homeost Agents 2009; 23:119-124
14. Caldarola G, De Simone C, Carbone A, Tulli A, Amerio P, Feliciani C. TNFα and its receptors in psoriatic skin, before and after treatment with Etanercept. Int J Immunopathol Pharmacol 2009; 22:961-966
15. Di Leo E, Aloia AM, Nettis E, Cardinale F, Foti C, Distaso M, Ferrannini A, Vacca A. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009; 22:1131-1134
16. Castellani ML, Vecchiet J, Salini V, et al. Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance p in LAD2 human mast cells. Tranl Res 2009; 154:27-33.
17. Katsanos GS, Anogeianaki A, Orso C, Tetè S, Salini V, Antinolfi PL, Sabatino G. Mast cells and chemokines. J Biol Regul Homeost Agents 2008; 22:145-151
18. Hippe A, Homey B, Mueller-Homey A. Chemokines. Recent Results Cancer Res 2010; 180:35-50.
19. D'Haese JG, Demir IE, Friess H, Ceyhan GO. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin Ther Targets 2010; 14:207-19.
20. Ciardelli L, Garofoli F, Stronati M, et al. Human colostrum T lymphocytes and their effector cytokines actively aid the development of the newborn immune system. Int J Immunopathol Pharmacol 2008; 21:781-786
21. Galliera E, Locati M, Mantovani A, Corsi MM. Chemokines and bone remodeling. Int J Immunopathol Pharmacol 2008; 21:485-491
22. Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004; 91:1970-1976 (Pubitemid 40065527)
23. Mennini T, Giordano L, Mengozzi M, et al. Increased IL-8 levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Inflamm 2009; 7:39-44.
24. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL. Chemokines and their role in airway hyper-reactivity. Respir Res 2000; 1:54-61. (Pubitemid 34189258)
25. Okamoto T, Iwata S, Ohnuma K, Dang NH, Morimoto C. Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clin Exp Immunol 2009; 157:27-34.
26. Langer HF, Chavakis T. Leukocyte-endothelial interactions in inflammation. J Cell Mol Med 2009; 13:1211-1220
27. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control Trends in Immunol 2004; 25:75-84.
28. Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci 1993; 53:1391-1399 (Pubitemid 23288945)
29. Di Gioacchino M, Perrone A, Petrarca C, et al. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomelic allergoids. Int J Immunopathol Pharmacol 2008; 21:969-976
30. Hart PH. Regulation of the inflammatory response in asthma by mast cell products. Immunol Cell Biol 2001; 79:149-153
31. Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004; 25:563-568 (Pubitemid 39371146)
32. Guida G, Culla B, Scirelli T, et al. Exhaled nitric oxide and nitric oxide synthase expression in Hodgkin's disease. Int J Immunopathol Pharmacol 2009; 22:1027-1034
33. D'Agosto G, Trento E, Nosotti L, et al. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines. J Biol Regul Homeost Agents 2009; 23:155-164
34. Wells AD. New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting. J Immunol 2009; 182:6088-6094
35. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21:1-4.
36. Cencioni MT, Notturno F, Caporale CM, Creati B, Prencipe V, Battistini L, Uncini A. T cell response in acute motor axonal neuropathy. Int J Immunopathol Pharmacol 2009; 22:1043-1050
37. Ciprandi G, Cirillo I, Pistorio A, Di Gioacchino M, Fenoglio D. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis. J Biol Regul Homeost Agents 2009; 23:31-36.
38. Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90:421-429 (Pubitemid 17232873)
39. Wilms H, Rosenstiel P, Romero-Ramos M, et al. Suppression of map kinases inhibits microglial activation and attenuates neuronal cell death induced by α-synuclein protofibrils. Int J Immunopathol Pharmacol 2009; 22:897-909.
40. Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol 2009; 22:557-565
41. Shuvy M, BenYa'acov A, Zolotarov L, Lotan C, Ilan Y. Beta glycosphingolipids suppress rank expression and inhibit natural killer T cell and CD8+ accumulation in alleviating aortic valve calcification. Int J Immunopathol Pharmacol 2009; 22:911-918
42. Chiba Y, Sato S, Misawa M. GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma. Int J Immunopathol Pharmacol 2009; 22:929-935
43. Li Q, Kobayashi M, Wakayama Y, Inagaki H, Katsumata M, Hirata Y, Hirata K, Shimizu T, Kawada T, Park BJ, Ohira T, Kagawa T, Miyazaki Y. Effect of phytoncide from trees on human natural killer cell function. Int J Immunopathol Pharmacol 2009; 22:951-959
44. Luster AD. Antichemokine immunotherapy for allergic diseases. Curr Opin Allergy Clin Immunol 2001; 1:561-567
45. Chen Q, Carroll HP, Gadina M. The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006; 74:207-228
46. Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of subcutaneous anti-TNFα treatment in Italian patients. Int J Immunopathol Pharmacol 2009; 22:1147-1152
47. Meazza C, Travaglino P, Pagani S, Laarej K, Duse M, Bozzola M. Hyperimmunoglobulinaemia in babinga pygmies is present from infancy. Int J Immunopathol Pharmacol 2009; 22:1117-1120
48. Ferrara G, Losi M, D'Amico R, et al. Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol 2009; 22:669-678
49. Stelekati E, Bahri R, D'Orlando O, et al. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 2009; 31:665-676
50. Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol 2009; 22:879-888
51. Tarantino G, Conca P, Tarantino M, Di Minno MND, Grimaldi E, Chianese D, Riccio A, Scopacasa F, Capone D. Does spleen volume play a role in patients with HCV-related chronic hepatitis? Int J Immunopathol Pharmacol 2009; 22:1009-1017
52. Schillaci G, Rondelli F, Pirro M, Bagaglia F, Pucci G, Noya G, Mannarino E. Endothelial progenitor cells are mobilized after major laparotomic surgery in patients with cancer. Int J Immunopathol Pharmacol 2009; 22:1035-1041
53. Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S, Laghi Pasini F, Capecchi PL, Sebastiani GD, Galeazzi M. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol 2009; 22:1051-1058
54. Aiello FB, Furian L, Marino S, Marchini F, Cardillo M, De Fazio N, Rigotti P, Valente M. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols. Int J Immunopathol Pharmacol 2009; 22:1001-1007
55. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25:235-241 (Pubitemid 38501669)
56. Cabrelle A, Maschio N, Carraro S, et al. Apoptotic effect of cyclosporin A and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukaemia. J Biol Regul Homeost Agents 2009; 23:239-250
57. Colina M, Ciancio G, Garavini R, Conti M, Trotta F, Covoni M. Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis. Int J Immunopathol Pharmacol 2009; 22:1125-1129
58. Marasini B, Conciato L, Belloli L, Massarotti M. Systemic sclerosis and cancer. Int J Immunopathol Pharmacol 2009; 22:573-578
59. Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R. Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol 2009; 22:627-638
60. Sessa R, Di Pietro M, Schiavoni G, Macone A, Maras B, Fontana M, Zagaglia C, Nicoletti M, Del Piano M, Morrone S. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. Int J Immunopathol Pharmacol 2009; 22:659-668
61. Castellani ML, Kempuraj D, Salini V, et al. The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents 2009; 23:11-14
62. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med 2008; 358:1860-1861
63. Amedei A, Della Bella C, Niccolai E, Stanflin N, Benagiano M, Duranti R, Del Prete G, Murphy TF, D'Elios MM. Moraxella catarrhalis-specific TH1 cells in BAL fluids of chronic obstructive pulmonary disease patients. Int J Immunopathol Pharmacol 2009; 22:979-990
64. Zampetti A, Mastrofrancesco A, Flori E, Maresca V, Picardo M, Amerio P, Feliciani C. Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis. Int J Immunopathol Pharmacol 2009; 22:1067-1075
65. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL. Sublingual immunotherapy affects specific antibody and TGF-β serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22:1089-1096
66. Kaliener MA, Metcalfe DD. The Mast Cell in Health and Disease. Ed. Claude Lenfant 199, 62:1-880.